Related Experiment Video
Updated: Dec 18, 2025

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model
Published on: March 20, 2020
I'm Still Mom: Young Mothers Living With Advanced Breast Cancer
Debra M Lundquist1, Donna L Berry2, Marie Boltz3
1Massachusetts General Hospital Cancer Center.
Purpose:
To conduct a detailed content analysis of the theme "I'm still Mom" as described by young women living with advanced breast cancer.
Participants & Setting:
12 young adult women living with advanced breast cancer were recruited from across the United States.
Methodologic Approach:
van Manen's hermeneutic phenomenologic method was used to analyze qualitative data from interviews and establish subthemes.
Findings:
Women were a mean age of 36 years and had at least one child. The following three subthemes emerged from the overarching theme of I'm still Mom.
Implications For Nursing:
This study provides a foundation for additional research that can inform family-centered education and interventions to help align the parenting priorities of this cohort of women, as well as optimize their quality of life.
Related Concept Videos
Cancer
Treatment Resistant Cancers
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Survival Analysis
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

